Ascendis Pharma (Brazil) Investor Sentiment

A1SN34 Stock  BRL 48.84  0.00  0.00%   
About 55% of Ascendis Pharma's investor base is interested to short. The analysis of current outlook of investing in Ascendis Pharma AS suggests that many traders are impartial regarding Ascendis Pharma's prospects. The current market sentiment, together with Ascendis Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ascendis Pharma AS stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at news.google.com         
Stifel starts Ascendis with a buy rating, sets 200 target By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Ascendis Pharma grows 7.7 percent this week, taking one-year gains to 45 percent - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Stocks To Watch Ascendis Pharma ADR Sees Relative Strength Rating Rise To 81 - Investors Business Da...
Google News at Macroaxis
over six months ago at news.google.com         
Russell Investments Group Ltd. Sells 4166 Shares of Ascendis Pharma AS - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Matisse Capital Raises Stake in Ascendis Pharma AS - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Lowered to Sell at StockNews.com - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma Expands Capital with Warrants and Shares - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
FDA Pushes Review Date For Ascendis Pharmas Hormone Disorder Candidate By Three Months - Yahoo Finan...
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Ascendis Pharma Is Rocketing Higher Today - Yahoo Singapore News
Google News at Macroaxis
over six months ago at news.google.com         
What Makes Ascendis Pharma AS a New Buy Stock - Yahoo News UK
Google News at Macroaxis
over six months ago at news.google.com         
What Makes Ascendis Pharma AS a New Buy Stock - Yahoo Singapore News
Google News at Macroaxis
over six months ago at news.google.com         
An Update On Ascendis Pharmas Path To Profitability - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today - Ascendis Pharma NASDAQ...
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Receives Consensus Recommendation of Moderate Buy from Brokerages - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Ascendis Pharma AS Boasts Strong Q1 Growth - TipRanks.com - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ascendis Pharma that are available to investors today. That information is available publicly through Ascendis media outlets and privately through word of mouth or via Ascendis internal channels. However, regardless of the origin, that massive amount of Ascendis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ascendis Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ascendis Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ascendis Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ascendis Pharma alpha.

Ascendis Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio